Abstract
COVID-19 has resulted in a staggering death toll in the US: over 215,000 by mid-October 2020, according to the Centers for Disease Control and Prevention. Black and Latino Americans have experienced a disproportionate burden of COVID-19 morbidity and mortality, reflecting persistent structural inequalities that increase risk of exposure to COVID-19 and mortality risk for those infected. We estimate life expectancy at birth and at age 65 for 2020, for the total US population and by race and ethnicity, using four scenarios of deaths – one in which the COVID-19 pandemic had not occurred and three including COVID-19 mortality projections produced by the Institute for Health Metrics and Evaluation. Our medium estimate indicates a reduction in US life expectancy at birth of 1.13 years to 77.48 years, lower than any year since 2003. We also project a 0.87-year reduction in life expectancy at age 65. The Black and Latino populations are estimated to experience declines in life expectancy at birth of 2.10 and 3.05 years, respectively, both of which are several times the 0.68-year reduction for whites. These projections imply an increase of nearly 40% in the Black-white life expectancy gap, from 3.6 to over five years, thereby eliminating progress made in reducing this differential since 2006. Latinos, who have consistently experienced lower mortality than whites (a phenomenon known as the Latino or Hispanic paradox), would see their more than three-year survival advantage reduced to less than one year.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institute on Aging under Award Number T32AG000037. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Princeton University IRB determined that this research, which consisted of secondary analysis of publicly available data, did not constitute human subjects research and was therefore not subject to IRB approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Research reported in this publication was supported by the National Institute on Aging under Award Number T32AG000037. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The October 15, 2020 revision updates the life expectancy estimates with the October 9, 2020 COVID-19 mortality projections produced by the Institute for Health Metrics and Evaluation (IHME). Data on COVID-19 deaths by race, ethnicity, and age have been updated to the October 7, 2020 version released by the National Center for Health Statistics (NCHS).
Data Availability
The data used in this study are all publicly available through the provided links.
https://data.cdc.gov/NCHS/Deaths-involving-coronavirus-disease-2019-COVID-19/ks3g-spdg
https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_07-508.pdf
https://www.census.gov/newsroom/press-kits/2020/population-estimates-detailed.html
Data Availability
The data used in this study are all publicly available through the provided links.
https://data.cdc.gov/NCHS/Deaths-involving-coronavirus-disease-2019-COVID-19/ks3g-spdg
https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_07-508.pdf
https://www.census.gov/newsroom/press-kits/2020/population-estimates-detailed.html
Data Availability
The data used in this study are all publicly available through the provided links.
https://data.cdc.gov/NCHS/Deaths-involving-coronavirus-disease-2019-COVID-19/ks3g-spdg
https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_07-508.pdf
https://www.census.gov/newsroom/press-kits/2020/population-estimates-detailed.html
Data Availability
The data used in this study are all publicly available through the provided links.
https://data.cdc.gov/NCHS/Deaths-involving-coronavirus-disease-2019-COVID-19/ks3g-spdg
https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_07-508.pdf
https://www.census.gov/newsroom/press-kits/2020/population-estimates-detailed.html